Measurements of autoantibodies showed that 96% of PBC patients were positive for AMA-M2, 60% were positive for anti-sp-100 antibodies, and 84% were positive for anti- gp210 antibodies. This evidence concerns the gene SP100 and primary biliary cholangitis.